The store will not work correctly when cookies are disabled.
3-((4-Naphthalen-1-yl)-2,5-dihydro-1H-pyrrol-3-yl)-amino)benzonitrile
ID: ALA4877101
PubChem CID: 164628903
Max Phase: Preclinical
Molecular Formula: C21H13N3O2
Molecular Weight: 339.35
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: N#Cc1cccc(NC2=C(c3cccc4ccccc34)C(=O)NC2=O)c1
Standard InChI: InChI=1S/C21H13N3O2/c22-12-13-5-3-8-15(11-13)23-19-18(20(25)24-21(19)26)17-10-4-7-14-6-1-2-9-16(14)17/h1-11H,(H2,23,24,25,26)
Standard InChI Key: KPRVTRYCSICYGC-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
14.9684 -7.9729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7856 -7.9729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0400 -7.1961 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3770 -6.7140 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.7183 -7.1961 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5439 -8.6712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6927 -10.0686 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5152 -10.0846 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9366 -9.3854 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2652 -8.6345 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.0785 -8.6342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4836 -9.3406 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2962 -9.3406 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7033 -8.6355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2920 -7.9290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4807 -7.9325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8175 -6.9447 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.9410 -6.9440 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.7047 -10.0483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1133 -10.7560 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.2996 -9.3498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7234 -8.6534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3322 -7.9403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5174 -7.9223 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0954 -8.6235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4890 -9.3338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 1 0
4 5 1 0
5 1 1 0
6 22 2 0
21 7 2 0
7 8 1 0
8 9 2 0
9 6 1 0
6 1 1 0
2 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
3 17 2 0
5 18 2 0
13 19 1 0
19 20 3 0
21 22 1 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 339.35 | Molecular Weight (Monoisotopic): 339.1008 | AlogP: 3.19 | #Rotatable Bonds: 3 |
Polar Surface Area: 81.99 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.55 | CX Basic pKa: ┄ | CX LogP: 2.79 | CX LogD: 2.79 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.72 | Np Likeness Score: -0.72 |
References
1. Serafim RAM, Sorrell FJ, Berger BT, Collins RJ, Vasconcelos SNS, Massirer KB, Knapp S, Bennett J, Fedorov O, Patel H, Zuercher WJ, Elkins JM.. (2021) Discovery of a Potent Dual SLK/STK10 Inhibitor Based on a Maleimide Scaffold., 64 (18.0): [PMID:34463505] [10.1021/acs.jmedchem.0c01579] |